GARDASIL 9
INJ SUS 10X0,5ML+20J
| SÚKL code | 0210637 |
|---|---|
| Name of the product | GARDASIL 9 |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | GARDASIL 9 |
| Supplement | INJ SUS 10X0,5ML+20J |
| Strenght | |
| Pharmaceutical form | Suspension for injection |
| Package | 10X0,5ML+20J |
| Route | Intramuscular use |
| Wrap type | Pre-filled syringe |
| Legal status | na lékařský předpis |
| Active substance |
HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 6 PROTEINUM L1) HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 11 PROTEINUM L1) HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 16 PROTEINUM L1) HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 18 PROTEINUM L1) HUMAN PAPILLOMA VIRUS TYPE 31 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 31 PROTEINUM L1) HUMAN PAPILLOMA VIRUS TYPE 33 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 33 PROTEINUM L1) HUMAN PAPILLOMA VIRUS TYPE 45 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 45 PROTEINUM L1) HUMAN PAPILLOMA VIRUS TYPE 52 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 52 PROTEINUM L1) HUMAN PAPILLOMA VIRUS TYPE 58 L1 PROTEIN (PAPILLOMAVIRI HUMANI TYPI 58 PROTEINUM L1) |
| ATC group | J07BM03 |
| ATC group name | PROTEIN LIDSKÉHO PAPILLOMAVIRU TYPU 6, 11, 16, 18, 31, 33, 45, 52, 58) |
Marketing authorisation information
| Registration Number | EU/1/15/1007/003 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Merck Sharp & Dohme B.V., Haarlem |
| MA Holder country | NIZOZEMSKO |
cz